Keywords
Last Name
Institution

Yaron Tomer

TitlePROFESSOR
InstitutionMount Sinai
DepartmentEndocrinology, Diabetes and Bone Disease
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Blackard JT, Kong L, Huber AK, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid. 2013 Jul; 23(7):863-70.
      View in: PubMed
    2. Hasham A, Zhang W, Lotay V, Haggerty S, Stefan M, Concepcion E, Dieterich DT, Tomer Y. Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways. J Autoimmun. 2013 Aug; 44:61-70.
      View in: PubMed
    3. Barbesino G, Tomer Y. Clinical review: Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab. 2013 Jun; 98(6):2247-55.
      View in: PubMed
    4. Lipner EM, Tomer Y, Noble JA, Monti MC, Lonsdale JT, Corso B, Stewart WC, Greenberg DA. HLA class I and II alleles are associated with microvascular complications of type 1 diabetes. Hum Immunol. 2013 May; 74(5):538-44.
      View in: PubMed
    5. Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res. 2012 Dec; 54(1-3):204-13.
      View in: PubMed
    6. Tomer Y, Hasham A, Davies TF, Stefan M, Concepcion E, Keddache M, Greenberg DA. Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. J Clin Endocrinol Metab. 2013 Jan; 98(1):E144-52.
      View in: PubMed
    7. Carluccio AL, Sundaram NK, Yanagisawa RT, Tomer Y. Apathetic thyrotoxicosis secondary to atypical subacute thyroiditis. Endocr Pract. 2012 Sep-Oct; 18(5):e127-9.
      View in: PubMed
    8. Huber AK, Finkelman FD, Li CW, Concepcion E, Smith E, Jacobson E, Latif R, Keddache M, Zhang W, Tomer Y. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J Immunol. 2012 Sep 15; 189(6):3043-53.
      View in: PubMed
    9. Eschler DC, Hasham A, Tomer Y. Cutting edge: the etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol. 2011 Oct; 41(2):190-7.
      View in: PubMed
    10. Hasham A, Tomer Y. The recent rise in the frequency of type 1 diabetes: who pulled the trigger? J Autoimmun. 2011 Aug; 37(1):1-2.
      View in: PubMed
    11. Stefan M, Jacobson EM, Huber AK, Greenberg DA, Li CW, Skrabanek L, Conception E, Fadlalla M, Ho K, Tomer Y. Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem. 2011 Sep 9; 286(36):31168-79.
      View in: PubMed
    12. Jacobson EM, Concepcion E, Ho K, Kopp P, Vono Toniolo J, Tomer Y. cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity. PLoS One. 2011; 6(4):e19200.
      View in: PubMed
    13. Akeno N, Smith EP, Stefan M, Huber AK, Zhang W, Keddache M, Tomer Y. IFN-a mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms. J Immunol. 2011 Apr 15; 186(8):4693-706.
      View in: PubMed
    14. Huber AK, Concepcion ES, Gandhi A, Menconi F, Smith EP, Keddache M, Tomer Y. Analysis of immune regulatory genes' copy number variants in Graves' disease. Thyroid. 2011 Jan; 21(1):69-74.
      View in: PubMed
    15. Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A. 2010 Sep 28; 107(39):16899-903.
      View in: PubMed
    16. Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010 Jul; 20(7):715-25.
      View in: PubMed
    17. Tomer Y, Sarapura V, Kahaly GJ. Thyroid disorders: it's very personal. Thyroid. 2010 Jul; 20(7):677-9.
      View in: PubMed
    18. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun. 2010 May; 34(3):J322-6.
      View in: PubMed
    19. Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, Stefan M, David CS, Tomer Y. Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun. 2010 Aug; 35(1):45-51.
      View in: PubMed
    20. Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-a. J Endocrinol Invest. 2011 Jan; 34(1):78-84.
      View in: PubMed
    21. Kong YC, Wei WZ, Tomer Y. Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation. Ann N Y Acad Sci. 2010 Jan; 1183:222-36.
      View in: PubMed
    22. Tomer Y, Menconi F. Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23(6):703-12.
      View in: PubMed
    23. Jacobson EM, Yang H, Menconi F, Wang R, Osman R, Skrabanek L, Li CW, Fadlalla M, Gandhi A, Chaturvedi V, Smith EP, Schwemberger S, Osterburg A, Babcock GF, Tomer Y. Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem. 2009 Dec 4; 284(49):34231-43.
      View in: PubMed
    24. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009 May-Jun; 32(3-4):231-9.
      View in: PubMed
    25. Atochina-Vasserman EN, Abramova EV, Tomer Y, Scott P, Nazarov VA, Kruglov SV, Beers MF, Gow AJ, Malyshev IY. SP-D-dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages. Bull Exp Biol Med. 2009 Apr; 147(4):415-20.
      View in: PubMed
    26. Tomer Y, Menconi F. Type 1 diabetes and autoimmune thyroiditis: the genetic connection. Thyroid. 2009 Feb; 19(2):99-102.
      View in: PubMed
    27. Villano MJ, Huber AK, Greenberg DA, Golden BK, Concepcion E, Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab. 2009 Apr; 94(4):1458-66.
      View in: PubMed
    28. Yin X, Latif R, Bahn R, Tomer Y, Davies TF. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Thyroid. 2008 Nov; 18(11):1201-6.
      View in: PubMed
    29. Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun. 2008 Dec; 31(4):339-44.
      View in: PubMed
    30. Menconi F, Monti MC, Greenberg DA, Oashi T, Osman R, Davies TF, Ban Y, Jacobson EM, Concepcion ES, Li CW, Tomer Y. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A. 2008 Sep 16; 105(37):14034-9.
      View in: PubMed
    31. Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008 Oct; 29(6):697-725.
      View in: PubMed
    32. Ban Y, Greenberg DA, Davies TF, Jacobson E, Concepcion E, Tomer Y. 'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab. 2008 Sep; 93(9):3589-96.
      View in: PubMed
    33. Vieland VJ, Huang Y, Bartlett C, Davies TF, Tomer Y. A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. Am J Hum Genet. 2008 Jun; 82(6):1349-56.
      View in: PubMed
    34. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun. 2008 Feb-Mar; 30(1-2):58-62.
      View in: PubMed
    35. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. Isr Med Assoc J. 2008 Jan; 10(1):3-7.
      View in: PubMed
    36. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab. 2008 Mar; 93(3):1077-81.
      View in: PubMed
    37. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am. 2007 Dec; 36(4):1051-66; x-xi.
      View in: PubMed
    38. Ridgway EC, Tomer Y, McLachlan SM. Update in thyroidology. J Clin Endocrinol Metab. 2007 Oct; 92(10):3755-61.
      View in: PubMed
    39. Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid. 2007 Oct; 17(10):949-61.
      View in: PubMed
    40. Yin X, Latif R, Tomer Y, Davies TF. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci. 2007 Sep; 1110:193-200.
      View in: PubMed
    41. Tomer Y, Menconi F, Davies TF, Barbesino G, Rocchi R, Pinchera A, Concepcion E, Greenberg DA. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun. 2007 Sep-Nov; 29(2-3):69-77.
      View in: PubMed
    42. Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007 Jun; 28(4):201-7.
      View in: PubMed
    43. Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun. 2007 Mar-May; 28(2-3):85-98.
      View in: PubMed
    44. Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, Tomer Y. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun. 2007 Apr; 8(3):205-14.
      View in: PubMed
    45. Knight AK, Serrano D, Tomer Y, Cunningham-Rundles C. CTLA-4 gene exon-1 +49 A/G polymorphism: lack of association with autoimmune disease in patients with common variable immune deficiency. J Clin Immunol. 2007 Jan; 27(1):95-100.
      View in: PubMed
    46. Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, Villanueva R, Tomer Y. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid. 2006 Apr; 16(4):351-5.
      View in: PubMed
    47. Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology. 2006 Apr; 43(4):661-72.
      View in: PubMed
    48. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev. 2005 Sep; 3(1):20-32.
      View in: PubMed
    49. Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest. 2005 Aug; 115(8):1972-83.
      View in: PubMed
    50. Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab. 2005 Aug; 90(8):4904-11.
      View in: PubMed
    51. Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol. 2005 Mar; 12(1):47-58.
      View in: PubMed
    52. Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology. 2005 Jun; 146(6):2684-91.
      View in: PubMed
    53. Tomer Y, Davies TF, Greenberg DA. What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol (Oxf). 2005 Feb; 62(2):258.
      View in: PubMed
    54. Siegel G, Tomer Y. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr Res. 2005; 31(1):51-8.
      View in: PubMed
    55. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet. 2005 Jan; 76(1):157-63.
      View in: PubMed
    56. Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J Clin Endocrinol Metab. 2004 Sep; 89(9):4562-8.
      View in: PubMed
    57. Tomer Y, Greenberg D. The thyroglobulin gene as the first thyroid-specific susceptibility gene for autoimmune thyroid disease. Trends Mol Med. 2004 Jul; 10(7):306-8.
      View in: PubMed
    58. Oppenheim Y, Ban Y, Tomer Y. Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity. Autoimmun Rev. 2004 Jul; 3(5):388-93.
      View in: PubMed
    59. Tomer Y, Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link? Am J Med. 2004 Jul 1; 117(1):60-1.
      View in: PubMed
    60. Levin L, Ban Y, Concepcion E, Davies TF, Greenberg DA, Tomer Y. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum Immunol. 2004 Jun; 65(6):640-7.
      View in: PubMed
    61. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 2004 May; 5(3):203-8.
      View in: PubMed
    62. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 2003 Dec; 4(8):586-93.
      View in: PubMed
    63. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A. 2003 Dec 9; 100(25):15119-24.
      View in: PubMed
    64. Levin L, Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev. 2003 Oct; 2(6):377-86.
      View in: PubMed
    65. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003 Oct; 24(5):694-717.
      View in: PubMed
    66. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet. 2003 Oct; 73(4):736-47.
      View in: PubMed
    67. Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity. 2003 Sep-Nov; 36(6-7):367-79.
      View in: PubMed
    68. Villanueva R, Greenberg DA, Davies TF, Tomer Y. Sibling recurrence risk in autoimmune thyroid disease. Thyroid. 2003 Aug; 13(8):761-4.
      View in: PubMed
    69. Oppenheim Y, Kim G, Ban Y, Unger P, Concepcion E, Ando T, Tomer Y. The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse. Clin Dev Immunol. 2003 Jun-Dec; 10(2-4):161-5.
      View in: PubMed
    70. Marder BA, Schröppel B, Lin M, Schiano T, Parekh R, Tomer Y, Murphy B. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant. 2003 Apr; 3(4):424-31.
      View in: PubMed
    71. Davies TF, Greenberg D, Tomer Y. The genetics of the autoimmune thyroid diseases. Ann Endocrinol (Paris). 2003 Feb; 64(1):28-30.
      View in: PubMed
    72. Tomer Y, Concepcion E, Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 2002 Dec; 12(12):1129-35.
      View in: PubMed
    73. Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R, Tomer Y. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril. 2002 Dec; 78(6):1240-3.
      View in: PubMed
    74. Ban Y, Greenberg DA, Concepcion ES, Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid. 2002 Dec; 12(12):1079-83.
      View in: PubMed
    75. Tomer Y. Genetic dissection of familial autoimmune thyroid diseases using whole genome screening. Autoimmun Rev. 2002 Aug; 1(4):198-204.
      View in: PubMed
    76. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf). 2002 Jul; 57(1):81-8.
      View in: PubMed
    77. Futterweit W, Dronova L, Tomer Y, Siegel S. Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril. 2002 Apr; 77(4):855-6; author reply 856-7.
      View in: PubMed
    78. Xu Y, Graves PN, Tomer Y, Davies TF. CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol. 2002 Feb; 215(2):133-40.
      View in: PubMed
    79. Villanueva R, Tomer Y, Greenberg DA, Mao C, Concepcion ES, Tucci S, Estilo G, Davies TF. Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol (Oxf). 2002 Jan; 56(1):45-51.
      View in: PubMed
    80. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab. 2002 Jan; 87(1):404-7.
      View in: PubMed
    81. Oppenheim Y, Yeh HC, Brandwein M, Tomer Y. Thyroid carcinoma in a patient with acromegaly. Thyroid. 2001 Dec; 11(12):1197-8.
      View in: PubMed
    82. Zhou Y, Dong Q, Louahed J, Dragwa C, Savio D, Huang M, Weiss C, Tomer Y, McLane MP, Nicolaides NC, Levitt RC. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol. 2001 Oct; 25(4):486-91.
      View in: PubMed
    83. Slavcheva E, Albanis E, Jiao Q, Tran H, Bodian C, Knight R, Milford E, Schiano T, Tomer Y, Murphy B. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation. 2001 Sep 15; 72(5):935-40.
      View in: PubMed
    84. Schneider AE, Tomer Y. Images in thyroidology. Onycholysis associated with hypothyroidism. Thyroid. 2001 Jul; 11(7):707.
      View in: PubMed
    85. Haczku A, Atochina EN, Tomer Y, Chen H, Scanlon ST, Russo S, Xu J, Panettieri RA, Beers MF. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol. 2001 Jul; 25(1):45-50.
      View in: PubMed
    86. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab. 2001 Apr; 86(4):1687-93.
      View in: PubMed
    87. Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, Vink A, Renauld J, Van Snick J, Nicolaides NC, Levitt RC, Haczku A. Interleukin 9 promotes influx and local maturation of eosinophils. Blood. 2001 Feb 15; 97(4):1035-42.
      View in: PubMed
    88. Tomer Y. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid. 2001 Feb; 11(2):167-9.
      View in: PubMed
    89. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab. 2001 Jan; 86(1):446-9.
      View in: PubMed
    90. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid. 2000 Sep; 10(9):791-8.
      View in: PubMed
    91. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab. 2000 Apr; 85(4):1545-9.
      View in: PubMed
    92. Tomer Y. Unilateral ophthalmopathy in a patient with Hashimoto's thyroiditis. Thyroid. 2000 Jan; 10(1):99-100.
      View in: PubMed
    93. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab. 1999 Dec; 84(12):4656-64.
      View in: PubMed
    94. Tomer Y, Barak V, Gilburd B, Shoenfeld Y. Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol. 1999 Sep-Oct; 17(5):521-6.
      View in: PubMed
    95. Krause I, Tomer Y, Elias D, Blank M, Gilburd B, Cohen IR, Shoenfeld Y. Inhibition of diabetes in NOD mice by idiotypic induction of SLE. J Autoimmun. 1999 Aug; 13(1):49-55.
      View in: PubMed
    96. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 1998 Dec; 83(12):4321-7.
      View in: PubMed
    97. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet. 1998 Dec; 63(6):1749-56.
      View in: PubMed
    98. Tomer Y. Calculating the anion gap for patients with acidosis and hyperglycemia. Ann Intern Med. 1998 Nov 1; 129(9):753.
      View in: PubMed
    99. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 1998 Sep; 83(9):3290-5.
      View in: PubMed
    100. Barbesino G, Tomer Y, Concepcion E, Davies TF, Greenberg DA. Linkage analysis of candidate genes in autoimmune thyroid disease: 1. Selected immunoregulatory genes. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 1998 May; 83(5):1580-4.
      View in: PubMed
    101. Tomer Y, Sherer Y, Shoenfeld Y. Autoantibodies, autoimmunity and cancer (review). Oncol Rep. 1998 May-Jun; 5(3):753-61.
      View in: PubMed
    102. Tomer Y, Davies TF. The genetic susceptibility to Graves' disease. Baillieres Clin Endocrinol Metab. 1997 Oct; 11(3):431-50.
      View in: PubMed
    103. Tomer Y, Lider O, Gilburd B, Hershkoviz R, Meroni PL, Wiik A, Shoenfeld Y. Anti-neutrophil cytoplasmic antibody-enriched IgG induces adhesion of human T lymphocytes to extracellular matrix proteins. Clin Immunol Immunopathol. 1997 Jun; 83(3):245-53.
      View in: PubMed
    104. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab. 1997 May; 82(5):1645-8.
      View in: PubMed
    105. Tomer Y, Barbesino G, Greenberg D, Davies TF. The immunogenetics of autoimmune diabetes and autoimmune thyroid disease. Trends Endocrinol Metab. 1997 Mar; 8(2):63-70.
      View in: PubMed
    106. Tomer Y. Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic? Clin Immunol Immunopathol. 1997 Jan; 82(1):3-11.
      View in: PubMed
    107. Tomer Y, Viegas OA, Swissa M, Koh SC, Shoenfeld Y. Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome. Clin Exp Rheumatol. 1996 May-Jun; 14(3):275-80.
      View in: PubMed
    108. Tomer Y, Gilburd B, Sack J, Davies TF, Meshorer A, Burek CL, Rose NR, Shoenfeld Y. Induction of thyroid autoantibodies in naive mice by idiotypic manipulation. Clin Immunol Immunopathol. 1996 Feb; 78(2):180-7.
      View in: PubMed
    109. Shoenfeld Y, Beresovski A, Zharhary D, Tomer Y, Swissa M, Sela E, Zimran A, Zevin S, Gilburd B, Blank M. Natural autoantibodies in sera of patients with Gaucher's disease. J Clin Immunol. 1995 Nov; 15(6):363-72.
      View in: PubMed
    110. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology. 1995 Oct; 136(10):4415-23.
      View in: PubMed
    111. Blank M, Tomer Y, Stein M, Kopolovic J, Wiik A, Meroni PL, Conforti G, Shoenfeld Y. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol. 1995 Oct; 102(1):120-30.
      View in: PubMed
    112. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni PL, Wiik A, Shoenfeld Y. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum. 1995 Oct; 38(10):1375-81.
      View in: PubMed
    113. Blank M, Tomer Y, Slavin S, Shoenfeld Y. Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation. Scand J Immunol. 1995 Aug; 42(2):226-34.
      View in: PubMed
    114. Tomer Y, Lunenfeld B, Berezin M. [Andropause: myth or reality?]. Harefuah. 1995 Jun 15; 128(12):785-8.
      View in: PubMed
    115. Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, Shoenfeld Y. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J Rheumatol. 1995 Jun; 22(6):1068-74.
      View in: PubMed
    116. Blank M, Krause I, Lanir N, Vardi P, Gilburd B, Tincani A, Tomer Y, Shoenfeld Y. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum. 1995 Jan; 38(1):115-22.
      View in: PubMed
    117. Tomer Y, Davies TF. Infections and autoimmune endocrine disease. Baillieres Clin Endocrinol Metab. 1995 Jan; 9(1):47-70.
      View in: PubMed
    118. Shoenfeld Y, Tomer Y, Blank M. A new experimental model for Wegener's granulomatosis. Isr J Med Sci. 1995 Jan; 31(1):13-6.
      View in: PubMed
    119. Blank M, Manosroi J, Tomer Y, Manosroi A, Kopolovic J, Charcon-Polak S, Shoenfeld Y. Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idiotypic antibody-saporin conjugate. Clin Exp Immunol. 1994 Dec; 98(3):434-41.
      View in: PubMed
    120. Hojnik M, Gilburd B, Ziporen L, Blank M, Tomer Y, Scheinberg MA, Tincani A, Rozman B, Shoenfeld Y. Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus. 1994 Dec; 3(6):515-21.
      View in: PubMed
    121. Tomer Y, Blank M, Shoenfeld Y. Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies. Arthritis Rheum. 1994 Aug; 37(8):1236-44.
      View in: PubMed
    122. Rosen R, Tomer Y, Carel R, Weinberger A. Serum 17-beta-estradiol and testosterone levels in asymptomatic hyperuricaemic men. Clin Rheumatol. 1994 Jun; 13(2):219-23.
      View in: PubMed
    123. Adler Y, Zandman-Goddard G, Ravid M, Avidan B, Zemer D, Ehrenfeld M, Shemesh J, Tomer Y, Shoenfeld Y. Usefulness of colchicine in preventing recurrences of pericarditis. Am J Cardiol. 1994 May 1; 73(12):916-7.
      View in: PubMed
    124. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev. 1993 Feb; 14(1):107-20.
      View in: PubMed
    125. Tomer Y, Graves PN, Jin A, Schwartz AE, Friedman EW, Davies TF. Liquid hybridization analysis of TSH receptor mRNA in normal and abnormal human thyroid tissues. Thyroid. 1993; 3(3):219-24.
      View in: PubMed
    126. Gilburd B, Stein M, Tomer Y, Tanne D, Abramski O, Chapman Y, Ahiron A, Blank M, Shoenfeld Y. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic? Autoimmunity. 1993; 16(1):23-7.
      View in: PubMed
    127. Tomer Y, Buskila D, Shoenfeld Y. Pathogenic significance and diagnostic value of lupus autoantibodies. Int Arch Allergy Immunol. 1993; 100(4):293-306.
      View in: PubMed
    128. Graves PN, Tomer Y, Davies TF. Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun. 1992 Sep 16; 187(2):1135-43.
      View in: PubMed
    129. Tomer Y, Shoenfeld Y. Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol. 1992 Jul-Aug; 10(4):391-3.
      View in: PubMed
    130. Tomer Y, Huber GK, Davies TF. Human chorionic gonadotropin (hCG) interacts directly with recombinant human TSH receptors. J Clin Endocrinol Metab. 1992 Jun; 74(6):1477-9.
      View in: PubMed
    131. Tomer Y, Neufeld MY, Shoenfeld Y. Coma with triphasic wave pattern in EEG as a complication of temporal arteritis. Neurology. 1992 Feb; 42(2):439-40.
      View in: PubMed
    132. Tomer Y, Shoenfeld Y. The relationship between the lupus anticoagulant, anticardiolipin antibodies and antiphospholipid antibodies. Isr J Med Sci. 1992 Jan; 28(1):38-40.
      View in: PubMed
    133. Tomer Y, Mendlovic S, Kukulansky T, Mozes E, Shoenfeld Y, Globerson A. Effects of aging on the induction of experimental systemic lupus erythematosus (SLE) in mice. Mech Ageing Dev. 1991 May; 58(2-3):233-44.
      View in: PubMed
    134. Tomer Y, Cohen J, Shoenfeld Y. [Clinical aspects of the antiphospholipid antibody syndrome]. Harefuah. 1991 May 1; 120(9):514-20.
      View in: PubMed
    135. Tomer Y, Kessler A, Eyal A, Many A, Shoenfeld Y. Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol. 1991 Jan; 18(1):95-7.
      View in: PubMed
    136. Stein M, Tomer Y, Shoenfeld Y. [Extreme bilirubinemia in hepatitis A associated with G6PD-deficiency]. Harefuah. 1990 Sep; 119(5-6):126-8.
      View in: PubMed
    137. Huminer D, Tomer Y, Pitlick S, Shoenfeld Y. Autoantibodies in cancer patients: are they tumor related or age related? Autoimmunity. 1990; 5(3):232-3.
      View in: PubMed
    138. Tomer Y, Shoenfeld Y. The significance of T suppressor cells in the development of autoimmunity. J Autoimmun. 1989 Dec; 2(6):739-58.
      View in: PubMed
    139. Tomer Y, Blank M. [Ageing and autoimmunity]. Harefuah. 1989 Jun 15; 116(12):652-6.
      View in: PubMed
    140. Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest. 1988 Jul; 17(5):389-424.
      View in: PubMed
    141. Ben-Yehuda O, Tomer Y, Shoenfeld Y. Advances in therapy of autoimmune diseases. Semin Arthritis Rheum. 1988 Feb; 17(3):206-20.
      View in: PubMed
    142. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity. 1988; 1(2):141-9.
      View in: PubMed
    143. Tomer Y, Zamir R, Brautbar C, Pinkhas J, Weinberger A. HLA antigens in patients with Heberden's nodes. Isr J Med Sci. 1988 Jan; 24(1):24-7.
      View in: PubMed
    144. Tomer Y, Ben-Yehuda O, Shoenfeld Y. [Treatment of autoimmune diseases]. Harefuah. 1987 Jun 15; 112(12):608-12.
      View in: PubMed
    Tomer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067